Greenvironment Oy, Capstone's distributor in Finland and Germany, sent the Chatsworth, Calif., company an initial $3.8 million order for its C200 microturbine systems, which will be used for biogas applications. Deliveries are slated to begin in September of next year and to complete in December 2009. Capstone shares were adding 11 cents, or 9.6%, to $1.26.
Metabasis Therapeutics (MBRX) was another big price gainer, after the European Commission granted orphan medicinal product status to its proposed primary liver cancer treatment, MB07133. That entitles Metabasis to 10 years of market exclusivity if the drug is approved for that indication, as well as grant eligibility and other benefits.
The designation is given to drug candidates for treatment of life-threatening or chronically debilitating diseases that are rare in the European Union. Shares of the California-based biopharma company were spiking 15.9% to $3.29.But Micron Technology (MU - Get Report), of Boise, Idaho, fell 4.2% after the chipmaker